Magzter GOLD ile Sınırsız Olun

Magzter GOLD ile Sınırsız Olun

Sadece 9.000'den fazla dergi, gazete ve Premium hikayeye sınırsız erişim elde edin

$149.99
 
$74.99/Yıl

Denemek ALTIN - Özgür

Bain weighs block deal to sell ₹1,700 cr Emcure stake

Mint New Delhi

|

March 31, 2025

Global private equity firm Bain Capital is looking to divest its stake in listed pharmaceutical manufacturer Emcure Pharmaceuticals Ltd through a substantial block deal, according to two people with knowledge of the development.

- Sneha Shah & Ranjani Raghavan

Bain weighs block deal to sell ₹1,700 cr Emcure stake

The move comes after the lock-in period for selling the shares in the Pune-based company got over in February this year. As per Indian market regulations, a lock-in period for certain categories such as anchor investors and pre-listing investors is mandatory, during which period they are prohibited from selling their shares.

"Bain Capital is likely to sell stake worth over $200 million (₹1,700 crore) in the company. It has appointed investment bank Kotak Mahindra Capital Co. to help it with the deal," one of the people cited above said, requesting anonymity.

Mint New Delhi'den DAHA FAZLA HİKAYE

Mint New Delhi

Mint New Delhi

120 ways of cooking your vegetables

Restaurateur Camellia Panjabi's new cookbook is a deep dive into the country’s vast and varied vegetarian cuisine

time to read

4 mins

November 29, 2025

Mint New Delhi

Tiramisu is trending and nobody is complaining

Tiramisu, tiramisu latte, rasgulla tiramisu, masala chai tiramisu, tiramisu tres leches—it seems like almost every café or restaurant across the country has some version of the Italian dessert on its menu.

time to read

4 mins

November 29, 2025

Mint New Delhi

Mint New Delhi

Former DBS CEO is Temasek India’s new non-exec chair

Piyush Gupta, the former chief executive of DBS Group, has joined Singaporean state-owned multinational investment firm Temasek as India chairman, albeit in a non-executive role, and will work with Ravi Lambah, head of India and strategic initiatives, the firm said, He will join on 1 December.

time to read

1 mins

November 29, 2025

Mint New Delhi

Mint New Delhi

Everything that’s wrong with India’s development story

This new book inquires into the conditions under which India has tried to develop in the past 75-plus years

time to read

4 mins

November 29, 2025

Mint New Delhi

Mint New Delhi

Two women navigate love and politics in Mumbai

This novel's charm lies less in plot twists and more in the lived-in world of the millennial women it depicts accurately

time to read

3 mins

November 29, 2025

Mint New Delhi

Art Deco feels in Indian fashion

The 100-year-old style has inspired design worldwide. Why doesn't it have a big presence in Indian fashion?

time to read

4 mins

November 29, 2025

Mint New Delhi

Mint New Delhi

Mystery loves company

A Man on the Inside was one of Netflix's best shows last year. It was based on a delightful (and borderline unbelievable) Chilean documentary called The Mole Agent, created by the infallible Mike Schur (The Good Place, The Office (US), Brooklyn Nine-Nine, all streaming in India on Netflix) and starred the all-time king of sitcom comedy, the one and only Ted Danson.

time to read

3 mins

November 29, 2025

Mint New Delhi

LIC'S response to voting on RIL, Adani resolutions

A Mint story on Friday reported how Life Insurance Corp. of India Ltd, or LIC, had approved or never opposed resolutions proposed before shareholders of Reliance Industries Ltd (RIL) or any Adani Group company since 1 April 2022, even as it rejected similar proposals at other large companies.

time to read

1 min

November 29, 2025

Mint New Delhi

Mint New Delhi

Recreating Dharmendra's timeless style

The late movie superstar was the definition of what it means to have a strong personal style

time to read

1 min

November 29, 2025

Mint New Delhi

Mint New Delhi

Speciality chemical makers are betting big on pharma

The Street is gravitating toward speciality chemical manufacturers that supply contract development and manufacturing organizations (CDMO) and active pharmaceutical ingredient (API) makers, as uncertainty looms over the chemicals sector.

time to read

1 mins

November 29, 2025

Listen

Translate

Share

-
+

Change font size